Heilbrigðisskýrslur - 01.12.1988, Síða 120

16. Cordtz T, Arpi M, Hpnberg PZ, Jepsen OB. Behandling og forlpb af 18 tilfælde
af purulent meningitis fra Danmark og Grpnland forársaget af
ampicillinresistente Haemophilus influenzae. Ugeskrift for læger 1987; 149:
3455-8
17. O'Callaghan CH, Morris A, Kirby SM, Shingler AH. Novel method for
detection of beta-lactamases by using a chromogenic cephalosporin substrate.
Antimicrob Agents & Chemother 1972; 1: 283-8
18. Ward JI, Margolis HS, Lum MKW, Fraser DW, Bender TR, Anderson P.
Haemophilus influenzae disease in Alaskan Eskimos: Characteristics of a
population with an unusual incidence of invasive disease. Lancet 1981; i: 1281-5
19. Ward JI, Gorman G, Phillips C, Fraser DW. Haemophilus influenzae type b
disease in a day-care center.J. Pediatrics 1978; 92: 713-17.
20. Ward JI, Fraser DW, Baraff LJ, Plikaytis BD. Haemophilus influenzae
meningitis.
A national Study of Secondary Spread in Household contacts. N E J Med 1979;
301: 122-26.
21. Granoff DM, Daum RS, Spread of Haemophilus influenzae type b : Recent
epidemiologic and therapeutic considerations. J Pediatrics 1980; 97: 854-60.
22. Istre GR, Conner JS, Broome CV, Hightower A, Hopkins RS. Risk factors for
primary invasive Haemophilus influenzae disease: Increased risk from day-care
attendance and school-aged household members. J Pediatrics 1984; 106: 190-
95.
23. Takala AK. Epidemiologic characteristics and risk factors for invasive
Haemophilus influenzae type b disease in a population with high vaccine
efficacy. Pediatr Inf Dis J 1989; 8:343-46.
24. Peltola H, Jónsdóttir K, Lystad A, Sievers CJ, Kallings I. Meningococcal
disease in Scandinavia. Brit Med J 1982; 284: 1618-21.
118